COPD is the sixth leading cause of death in the US
Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of ...
News Medical7h
Hospital-at-Home: Bridging Inpatient and Remote Care
Hospital-at-home initiatives use innovative technologies and sensors to deliver continuous care, improving patient quality of ...
Daily8h
GERD Increases Risks for COPD and Asthma, Study Confirms
It has been found in a recent study published in Heliyon that individuals who are genetically predisposed to having ...
Global Spirometer Market Size to Hit USD 2738.41 Million by 2032, Growing at a CAGR of 10.70% – SNS Insider
Advancements in technology, rising respiratory disease prevalence, and a growing emphasis on home-based healthcare drive robust growth in the spirometer market.Pune, Jan. 21, 2025 (GLOBE NEWSWIRE) -- ...
2minutemedicine.com1d
Verona’s Ohtuvayre shows promise in the treatment and management of Chronic Obstructive Pulmonary Disease
Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...
What are Zephyr Valves? Groundbreaking COPD treatment brings hope to Panhandle patients
After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...
The Thaiger1d
Thailand plans five-year strategy to tackle PM2.5 pollution
Thailand's five-year plan targets PM2.5 pollution with research, innovation, and collaboration, aims to improve public health.
COPD market to expand with AstraZeneca’s focus on biologics and strong portfolio growth
AstraZeneca’s Fasenra, an IL-5-targeting monoclonal antibody already approved for asthma, represents a promising contender ...
pulmonologyadvisor6d
Ensifentrine Is a Promising Ancillary COPD Treatment Option
Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...